Table 1.
Isolate Treatment | %Inhibition against C falcatum |
||
---|---|---|---|
cfNAV | cfCHA | Cf8436 | |
Stenotrophomonas acidaminiphila TRD10 | 39.52 j | 38.26kl | 34.26mn |
Ochrobactrum anthropi TRD11 | 31.43 k | 34.1m | 28.96° |
Ochrobactrum intermedium TRD14 | 61.18 a | 58.8b | 53.48b |
Bacillus safensis PK1 | 53.5 b | 40.47ijk | 43.31ghi |
Bacillus megaterium PK2 | 52.29bc | 42.67ghi | 46.05fg |
Sphingobacterium thalpophilum PK6 | 41.37 ij | 37.65klm | 36.71lm |
Acinetobacter sp. PK9 | 60.44 a | 51.63 de | 49.75de |
Acinetobacter sp. PK10 | 50.46 cd | 53.32cd | 49.61 de |
Stenotrophomonas acidaminiphila RSC6 | 51.04 cd | 41hij | 47.68ef |
Sphingobacterium thalpophilum RSC24 | 48.64 de | 42.81gh | 43.82gh |
Escherichia sp. RSC25 | 28.97 k | 40.06ijk | 37.54kl |
Bacillus sp. RSC29 | 51.07 bcd | 57.05b | 50.09cd |
Enterobacter sp. RSC32 | 44.37 gh | 44.27gh | 40.43ijk |
Bacillus sp. KR91 | 58.65 a | 56.89bc | 53.12bc |
Cronobacter muytjensii VRE6 | 42.58 ghi | 45.05g | 36.22lm |
Enterobacter cloacae VRE7 | 52.38 bc | 39.16jkl | 38.67jkl |
Pseudomonas sp. VRE8 | 41.27 ij | 45.03g | 44.42fg |
Bacillus thuringiensis VRE11 | 45.34 fg | 46.02 fg | 36.25lm |
Pseudomonas aeruginosa VRE12 | 54.17 b | 49.95 de | 45.38fg |
Sphingobacterium sp. VRE29 | 48.55 de | 36.11 lm | 34.78mn |
Escherichia sp. VRE34 | 61.11a | 69.64 a | 58.96a |
Pseudomonas sp. S1 | 41.68 hij | 37.7klm | 32.51n |
Pseudomonas plecoglossicida S2 | 47.27 ef | 51.93 de | 39.13jk |
Pseudomonas sp. S4 | 45.24 fg | 38.63kl | 39.1jkl |
Bacillus safensis B1 | 44.37gh | 45.12g | 41.06hij |
Bacillus subtilis C1 | 50.46 cd | 48.85 ef | 51.2bc |
*Carbendazim (0.01 ppm) | 20.22 | 22.37 | 27.98 |
*Carbendazim (0.05 ppm) | 59.39 | 50.84 | 61.51 |
*Carbendazim (0.1 ppm) | 80.26 | 79.15 | 83.06 |
*Carbendazim (0.3 ppm) | 100 | 100 | 100 |
Fungicide.